Views & Analysis | Perspectives on pharma industry issues

R&D

Inspection readiness is now a commercial question

Manufacturers of advanced therapies are discovering that a digital quality system does more than satisfy inspectors.

Digital

Abstract AI concept, turquoise hexagonals on dark background

Sponsored

The hardest part of becoming an AI-first company: It’s not t...

Axtria president and CEO Jaswinder Chadha on the culture and governance decisions behind his company’s AI transformation.

R&D

A certificate of analysis should be evidence, not a sales do...

Regulators weighing peptide bulk substances can ask whether today's documentation rules fit the risks of this supply chain.

R&D

From phase 1 to phase 3: Scaling radiopharmaceutical trials

Success in radiopharmaceutical development depends on creating and maintaining an integrated, scalable system.

Patients

pharmaphorum podcast Episode 285, Donna Cryer, CryerHealth, LLC

Patients not just at the table, but creating their own: In c...

Donna Cryer, founding partner and Chief Patient Officer of CryerHealth, LLC discusses why is patient inclusion is not the same as patient leadership.

Articles

A room with a view: patient centricity

‘Putting patients at the heart of the business’ is key to pharma but a meaningless phrase unless it’s applications is understood as Alex Butler explains. If we want to put patients first, tactics before strategy is the noise of defeat. There is little doubt that one of the hot topics of 2011 …

Articles

A room with a view: the future of EMR and patient support - ...

Alex Butler explores electronic medical records and the key to their success and asks are ‘big’ data the true revolution in healthcare offered by a socialised internet? With the majority of the discussion over the last couple of weeks focussed on the launch of Google+ I will once again demonstrate my fingers lack…

Articles

Emerging markets – the new gold rush? (part 2)

Amit Vaidya continues with his advice on entering emerging markets. A decision to enter emerging markets is a joined-up cross-company and cross-functional approach that could involve some or all of the...

Sales & Marketing

Sponsored

Solution Spotlight: BrandPRO Biopharma

Strong strategy on paper can unravel when priorities collide. BrandPRO Biopharma gives pharmaceutical teams a place to put their decisions to the test

Sales & Marketing

Benefits of marketing with AI tools, upward trajectory graph

Ending rational disengagement: Bridging the strategy-reality...

Organisations must secure strategic buy-in, embed platforms in existing workflows, and provide reps with actionable physician-ready hypotheses.

Digital

Sponsored

The hardest part of becoming an AI-first company: It’s not t...

Axtria president and CEO Jaswinder Chadha on the culture and governance decisions behind his company’s AI transformation.

Digital

Sponsored

Antiviral development in the age of AI: From pre-IND to earl...

hVIVO experts discuss how advancements in AI and machine learning are pushing industry beyond the bounds of a traditional "one virus, one drug" model.